Shu Hui Chen
Corporate Officer/Principal bij WUXI PHARMATECH (CAYMAN) INC. (ADR)
Actieve functies van Shu Hui Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - | - |
Chief Tech/Sci/R&D Officer | 01-01-2004 | - |
Loopbaan van Shu Hui Chen
Eerdere bekende functies van Shu Hui Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
WUXI APPTEC CO., LTD. | Chief Tech/Sci/R&D Officer | 01-01-2004 | 23-03-2016 |
Corporate Officer/Principal | 01-01-2004 | 10-04-2024 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-01-1998 | 01-01-2004 |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01-01-1995 | 01-01-1997 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-1995 | 01-01-1995 |
Opleiding van Shu Hui Chen
Yale University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
China | 4 |
Operationeel
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
- Beurs
- Insiders
- Shu Hui Chen
- Ervaring